SEC Form 4 · accession 0001144204-15-011064
Aevi Genomic Medicine, Inc. · GNMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sol J Barer
Director
Period of report
Feb 18, 2015
Accepted (ET)
Feb 20, 2015 · 6:00 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001138776
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option Award (right to buy)F1 | $7.01 | Feb 18, 2015 | A | 80,000 | A | — | Feb 18, 2025 | Common Stock | 80,000 | 80,000 | D |
Explanation of responses
- F1The option award vests in its entirety on the first anniversary of the grant date.
Remarks
Exhibit 24 - Power of Attorney